651O Pembrolizumab (pembro) + carboplatin (carbo) + paclitaxel (pacli) as first-line (1L) therapy in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Phase VI KEYNOTE-B10 study
| Autor: | M.R. Dzienis, J.E. Cundom, C.S. Fuentes, A.R. Hansen, M.J. Nordlinger, A.V. Pastor, P. Oppelt, A. Neki, R.W. Gregg, I.P.F. Lima, F.A. Franke, G.F. da Cunha Junior, J.E. Tseng, T. Loree, A.J. Joshi, J.S. Mccarthy, N. Naicker, Y. Sidi, B. Gumuscu, G. De Castro |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S839-S840 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.07.775 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|